Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06527079
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-24
Brief Title:
Evaluation of Clinical Decision Support in Opioid Tapering
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation of Clinical Decision Support in Opioid Tapering
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The 2022 CDC clinical practice guideline for prescribing opioids for pain recommends that when tapering a patients opioid dose doses should be decreased at a slow rate to reduce the risk of withdrawal symptoms overdose and to promote tolerance of the tapering This project will evaluate a clinical decision support CDS tool in the form of a clinical care pathway that gives providers information recommendations and educational material on strategies for opioid tapering Primary care providers will be randomized at the clinic location to a control arm or intervention arm The control arm will have the clinical care pathway available but will not be reminded of the pathway when tapering a patient The intervention arm will receive a nudge when prescribing a tapering opioid strategy to a patient to use the clinical care pathway The rate of opioid tapering in line with CDC guidelines will be examined as well as long-term patient outcomes of opioid overdose or poisoning using existing patient health records The study period will be approximately 18 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None